Related Experiment Video
Updated: Mar 13, 2026

Optimizing the Growth of Endothiapepsin Crystals for Serial Crystallography Experiments
Published on: February 4, 2021
Improving Biopharmaceutical Properties of Vinpocetine Through Cocrystallization
Samuel Golob1, Miranda Perry2, Matteo Lusi2
1Department of Chemical and Pharmaceutical Sciences, University of Trieste, Italy.
Abstract:
Vinpocetine is a poorly water soluble weakly basic drug (pKa = 7.1) used for the treatment of several cerebrovascular and cognitive disorders. Because existing formulations exhibit poor bioavailability and scarce absorption, a dosage form with improved pharmacokinetic properties is highly desirable. Cocrystallization represents a promising approach to generate diverse novel crystal forms and to improve the aqueous solubility and in turn the oral bioavailability. In this article, a novel ionic cocrystal of vinpocetine is described, using boric acid as a coformer, and fully characterized (by means of differential scanning calorimetry, solid-state nuclear magnetic resonance, powder and single-crystal X-ray diffraction, and powder dissolution test). Pharmacokinetic performance was also tested in a human pilot study. This pharmaceutical ionic cocrystal exhibits superior solubilization kinetics and modulates important pharmacokinetic values such as maximum concentration in plasma (Cmax), time to maximum concentration (tmax), and area under the plasma concentration-time curve (AUC) of the poorly soluble vinpocetine and it therefore offers an innovative approach to improve its bioavailability.
More Related Videos
Related Concept Videos
Drug Product Performance: In Vitro–In Vivo Correlation
Recrystallization: Solid–Solution Equilibria
Bioavailability Enhancement: Drug Solubility Enhancement
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
In Vitro Drug Dissolution: Alternative Methods
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

